FDA Adds New Warning for Ileus to Semaglutide (Ozempic) Label

[madman]

FDA Adds New Warning for Ileus to Semaglutide (Ozempic) Label

The FDA warns semaglutide (Ozempic) users of increased ileus risk and hypoglycemia with insulin secretagogues.

www.hcplive.com

The FDA warns semaglutide (Ozempic) users of increased ileus risk and hypoglycemia with insulin secretagogues.

 

[madman]

To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.

Accept third party cookies